Stockreport

Regulus: It Is Finding Its Stride Despite Initial Setback In Targeting ADPKD [Seeking Alpha]

Regulus Therapeutics Inc.  (RGLS) 
Last regulus therapeutics inc. earnings: 3/12 04:37 pm Check Earnings Report
US:NASDAQ Investor Relations: regulusrx.com/investors
PDF Additional results from cohort 3 of phase 1b study, using RGLS8429 for patients with ADPKD, expected in mid-2024; Higher dose of 3 mg/kg of drug being deployed for this [Read more]